PubRank

Nilanjan Chatterjee

Author PubWeight™ 358.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010 23.08
2 A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007 22.96
3 Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007 21.18
4 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010 20.01
5 Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008 17.65
6 Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010 9.07
7 A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009 8.39
8 A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009 5.62
9 NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005 5.01
10 Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009 4.48
11 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010 3.93
12 Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet 2010 3.91
13 Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 2009 3.76
14 Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012 3.69
15 Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics 2007 3.57
16 Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 2002 3.19
17 A new statistic and its power to infer membership in a genome-wide association study using genotype frequencies. Nat Genet 2009 3.06
18 Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 2008 3.04
19 Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 2009 3.00
20 Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008 2.49
21 Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006 2.48
22 Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012 2.26
23 The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009 2.22
24 Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009 2.17
25 Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 2006 2.06
26 Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Genet Epidemiol 2008 2.04
27 Analysis of case-control studies of genetic and environmental factors with missing genetic information and haplotype-phase ambiguity. Genet Epidemiol 2005 2.02
28 Shrinkage Estimators for Robust and Efficient Inference in Haplotype-Based Case-Control Studies. J Am Stat Assoc 2009 2.00
29 Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res 2013 1.99
30 Genome-wide association study of glioma and meta-analysis. Hum Genet 2012 1.96
31 Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003 1.95
32 Flexible design for following up positive findings. Am J Hum Genet 2007 1.94
33 Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A 2011 1.93
34 C-reactive protein and risk of lung cancer. J Clin Oncol 2010 1.90
35 The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010 1.90
36 Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov 2011 1.87
37 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
38 Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A 2009 1.81
39 Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Pharmacogenomics 2006 1.77
40 Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 2011 1.77
41 RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate 2007 1.74
42 Testing gene-environment interaction in large-scale case-control association studies: possible choices and comparisons. Am J Epidemiol 2011 1.69
43 Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007 1.68
44 Hepatitis C virus load and survival among injection drug users in the United States. Hepatology 2005 1.66
45 Testing in semiparametric models with interaction, with applications to gene-environment interactions. J R Stat Soc Series B Stat Methodol 2009 1.65
46 Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk. Cancer 2012 1.58
47 Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007 1.58
48 A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. Am J Hum Genet 2012 1.57
49 Gene-environment interactions in genome-wide association studies: a comparative study of tests applied to empirical studies of type 2 diabetes. Am J Epidemiol 2011 1.55
50 The association of telomere length and genetic variation in telomere biology genes. Hum Mutat 2010 1.53
51 Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One 2009 1.52
52 Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res 2010 1.51
53 Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007 1.49
54 Exploiting Hardy-Weinberg equilibrium for efficient screening of single SNP associations from case-control studies. Hum Hered 2007 1.47
55 Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol 2011 1.47
56 Using cases to strengthen inference on the association between single nucleotide polymorphisms and a secondary phenotype in genome-wide association studies. Genet Epidemiol 2010 1.43
57 Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006 1.43
58 Using principal components of genetic variation for robust and powerful detection of gene-gene interactions in case-control and case-only studies. Am J Hum Genet 2010 1.41
59 Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010 1.37
60 Predictors of sustained smoking cessation: a prospective analysis of chronic smokers from the alpha-tocopherol Beta-carotene cancer prevention study. Am J Public Health 2007 1.37
61 Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum Genet 2012 1.37
62 A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet 2011 1.36
63 Efficient study design for next generation sequencing. Genet Epidemiol 2011 1.36
64 Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer 2004 1.36
65 Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A 2012 1.36
66 Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet 2011 1.34
67 Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2007 1.34
68 Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 2013 1.34
69 A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenet Genomics 2011 1.33
70 Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004 1.32
71 Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 2008 1.32
72 Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet 2012 1.31
73 Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis. Int J Cancer 2007 1.31
74 Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2007 1.30
75 Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med 2008 1.30
76 Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 2007 1.28
77 Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2007 1.27
78 Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2008 1.27
79 Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol 2013 1.27
80 A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009 1.26
81 Retrospective analysis of haplotype-based case control studies under a flexible model for gene environment association. Biostatistics 2007 1.26
82 Joint effect of genes and environment distorted by selection biases: implications for hospital-based case-control studies. Cancer Epidemiol Biomarkers Prev 2002 1.25
83 Analysis of survival data from case-control family studies. Biometrics 2002 1.22
84 Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004 1.20
85 Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer. J Natl Cancer Inst 2008 1.20
86 IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2007 1.19
87 Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet 2011 1.17
88 Endogenous sex hormones and the risk of prostate cancer: a prospective study. Int J Cancer 2008 1.17
89 Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 2009 1.17
90 Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2004 1.16
91 Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol 2012 1.15
92 Haplotype-based regression analysis and inference of case-control studies with unphased genotypes and measurement errors in environmental exposures. Biometrics 2007 1.15
93 Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. Am J Epidemiol 2012 1.14
94 A cross-sectional investigation of regional patterns of diet and cardio-metabolic risk in India. Nutr J 2011 1.13
95 A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 1.12
96 Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Cancer Epidemiol Biomarkers Prev 2005 1.10
97 Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One 2009 1.08
98 Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry 2012 1.08
99 The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet 2011 1.08
100 A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 2008 1.08
101 Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev 2006 1.07
102 Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 2010 1.07
103 Robust estimation for homoscedastic regression in the secondary analysis of case-control data. J R Stat Soc Series B Stat Methodol 2013 1.06
104 GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005 1.05
105 PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res 2008 1.05
106 Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res 2011 1.03
107 Fat, fiber, fruits, vegetables, and risk of colorectal adenomas. Int J Cancer 2004 1.03
108 Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr 2007 1.02
109 Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history. Epidemiology 2002 1.02
110 Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc Natl Acad Sci U S A 2005 1.02
111 Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study. Am J Clin Nutr 2006 1.02
112 Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 2009 1.01
113 A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. Hum Genet 2009 1.01
114 Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS One 2009 1.01
115 Shrinkage estimation for robust and efficient screening of single-SNP association from case-control genome-wide association studies. Genet Epidemiol 2009 1.00
116 Measurement of spices and seasonings in India: opportunities for cancer epidemiology and prevention. Asian Pac J Cancer Prev 2010 1.00
117 Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. PLoS One 2012 1.00
118 Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev 2010 0.99
119 CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005 0.99
120 A partially linear tree-based regression model for multivariate outcomes. Biometrics 2009 0.99
121 High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev 2006 0.98
122 Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 2008 0.98
123 Empirical Performance of Cross-Validation With Oracle Methods in a Genomics Context. Am Stat 2011 0.98
124 Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol 2011 0.98
125 Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 2009 0.97
126 DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 2006 0.96
127 Analysis of Smoking Cessation Patterns Using a Stochastic Mixed-Effects Model With a Latent Cured State. J Am Stat Assoc 2008 0.96
128 Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification. Int J Gynecol Pathol 2008 0.95
129 Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 2015 0.94
130 Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet 2011 0.94
131 A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. Br J Haematol 2011 0.93
132 Can cervicography be improved? An evaluation with arbitrated cervicography interpretations. Am J Obstet Gynecol 2002 0.93
133 Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr 2004 0.93
134 Haplotype-based association analysis in cohort and nested case-control studies. Biometrics 2006 0.92
135 A note on the effect on power of score tests via dimension reduction by penalized regression under the null. Int J Biostat 2010 0.92
136 Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood 2008 0.92
137 A two-platform design for next generation genome-wide association studies. Genet Epidemiol 2012 0.92
138 Efficient p-value evaluation for resampling-based tests. Biostatistics 2011 0.92
139 Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2013 0.91
140 Common genetic variants and central adiposity among Asian-Indians. Obesity (Silver Spring) 2011 0.91
141 Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 2009 0.91
142 Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hum Genet 2012 0.90
143 Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 2007 0.90
144 Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II. J Infect Dis 2003 0.90
145 Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet 2011 0.90
146 Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005 0.89
147 Power of data mining methods to detect genetic associations and interactions. Hum Hered 2011 0.89
148 Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol 2010 0.89
149 Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 2006 0.88
150 The HER2 I655V polymorphism and breast cancer risk in Ashkenazim. Epidemiology 2003 0.87
151 Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2007 0.87
152 A haplotype-based test of association using data from cohort and nested case-control epidemiologic studies. Hum Hered 2004 0.87
153 Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking. Genet Epidemiol 2013 0.87
154 Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis 2007 0.86
155 Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol 2012 0.86
156 Case-control studies of gene-environment interaction: Bayesian design and analysis. Biometrics 2010 0.86
157 Analysis of epidemiologic studies of genetic effects and gene-environment interactions. IARC Sci Publ 2011 0.85
158 Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. Cancer Causes Control 2013 0.85
159 On a supplemented case-control design. Biometrics 2005 0.85
160 Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2003 0.84
161 GPC5 rs2352028 variant and risk of lung cancer in never smokers. Lancet Oncol 2010 0.84
162 Controlling the local false discovery rate in the adaptive Lasso. Biostatistics 2013 0.84
163 Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2009 0.83
164 Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev 2007 0.83
165 Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Hum Genet 2007 0.82
166 Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. Int J Cancer 2012 0.82
167 Leveraging family history in population-based case-control association studies. Genet Epidemiol 2014 0.82
168 Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet 2014 0.81
169 Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics. Am J Epidemiol 2014 0.81
170 SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. BMC Med Genet 2009 0.80
171 Urinary mutagenicity and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2003 0.80
172 Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer 2007 0.80
173 Bayesian inference for smoking cessation with a latent cure state. Biometrics 2009 0.80
174 Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in India. BMC Public Health 2011 0.80
175 Assessing disease risk in genome-wide association studies using family history. Epidemiology 2012 0.80
176 Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. Int J Cancer 2012 0.80
177 Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. Int J Mol Epidemiol Genet 2011 0.79
178 Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. Hum Hered 2011 0.79
179 Assessment of follow-up, and the completeness and accuracy of cancer case ascertainment in three areas of India. Cancer Epidemiol 2011 0.76
180 Tests for Gene-Environment Interactions and Joint Effects With Exposure Misclassification. Am J Epidemiol 2016 0.75
181 Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 2017 0.75
182 Fine mapping of 14q24.1 breast cancer susceptibility locus. Hum Genet 2011 0.75
183 Lessons Learned From Past Gene-Environment Interaction Successes. Am J Epidemiol 2017 0.75
184 Update on the State of the Science for Analytical Methods for Gene-Environment Interactions. Am J Epidemiol 2017 0.75
185 Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA). Hum Genet 2015 0.75
186 A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet 2011 0.75
187 Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases. Am J Epidemiol 2017 0.75